Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L1OC
|
|||
Former ID |
DCL001146
|
|||
Drug Name |
Anti-LT alpha
|
|||
Drug Type |
Antibody
|
|||
Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1] | |
Company |
Genentech
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Lymphotoxin-alpha (LTA) | Target Info | . | [1] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
NF-kappa B signaling pathway | ||||
TNF signaling pathway | ||||
Type I diabetes mellitus | ||||
HTLV-I infection | ||||
Herpes simplex infection | ||||
NetPath Pathway | TCR Signaling Pathway | |||
IL2 Signaling Pathway | ||||
RANKL Signaling Pathway | ||||
Panther Pathway | Apoptosis signaling pathway | |||
Pathway Interaction Database | IL4-mediated signaling events | |||
IL2 signaling events mediated by STAT5 | ||||
Reactome | TNFR2 non-canonical NF-kB pathway | |||
TNFs bind their physiological receptors | ||||
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | ||||
WikiPathways | Apoptosis |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of Genentech (2011). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.